Mode
Text Size
Log in / Sign up
N/A N=152 Randomized Other

Complications Associated With Central Venous Access in the NSICU: PICC vs CVC

PICC · Central Venous Catheter · Central Line · Neuro ICU · Neuroscience ICU

Enrolled (actual)
152
Serious AEs
3.3%
Results posted
Jul 2017
Primary outcome: Primary: Participants With Complications With Central Access Including Insertion — 14; 10 Participants — p=0.271

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
peripherally inserted central catheter (Device); centrally inserted central catheter (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Milton S. Hershey Medical Center
Primary completion
Dec 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Participants With Complications With Central Access Including Insertion
14; 10 0.271
SECONDARY
Number of Participants With Deep Venous Thrombosis
4; 0
SECONDARY
Number of Patients With Complications Related to Insertion
8; 6
SECONDARY
Number of Participants With a Central Line Associated Blood Stream Infection
0; 0

Summary

The goal of this study is to determine whether Peripherally Inserted Central Catheter or Centrally Inserted Venous Catheters have lower complication rates in the Neuroscience Intensive Care Unit. After admission to the Neuroscience ICU and if they require central access, patients will be randomized to receive a PICC or CVC and complications (such as pneumothorax, deep venous thrombosis, infection, etc.) will be tracked and compared between the two interventions.

Eligibility Criteria

Inclusion Criteria

Adult patients admitted to the NSICU, who require central access for the treatment of their illness.

Exclusion Criteria

  • Current or recent (within 1 month) diagnosis of bacteremia
  • Current or recent (within 1 year with confirmed resolution by imaging) deep venous thrombosis
  • Existing central access
  • Non-English speaking
  • Requirement for emergent central access and unable to obtain consent in an emergency setting
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02314520). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search